10.73% 30 September 2020 31 December 2019 Change DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin
and its subsidiary for the third quarter ended September 30, 2019 which the details are as follows: Unit: million Baht For 3-month period (July-Sep) 2019 2018 Change % Increase (Decrease) Revenue from
difference in the procedures to the extent that it will not materially change the work system and personnel provided in the application; (2) the rules and regulations of the derivatives exchange necessary for
liability was long-term loans from financial institutions. As of December 31, 2016 and June 30, 2017, the long-term loans from the financial institutions stood at Baht 63.81 million and Baht 63.87 million
hospital project. The Company saw total liabilities of Baht 206.63 million and Baht 267.05 million, as of 31 December 2016 and 30 September 2017, respectively. The major liability was long-term loans from
company not shown in financial statement, which are: 1. contingent liabilities arising from guarantee, [or] certifying or aval on bill of exchange; 2. contingent liability which the securities company shall
. contingent liabilities arising from guarantee, [or] certifying or aval on bill of exchange; 2. contingent liability which the securities company shall pay by cash or other assets when the specified incidents
465.65 million, as of December 31, 2018 and June 30, 2019, respectively. The major liability was long-term loans from financial institutions, and payables for fixed assets and retention payable. As of
for its new hospital project. The Company saw total liabilities of Baht 400.15 million and Baht 507.26 million, as of December 31, 2017 and September 30, 2018, respectively. The major liability was